These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 15459588

  • 1. Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM).
    Dunder K, Lind L, Zethelius B, Berglund L, Lithell H.
    Am Heart J; 2004 Oct; 148(4):596-601. PubMed ID: 15459588
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction.
    Dunder K, Lind L, Lagerqvist B, Zethelius B, Vessby B, Lithell H.
    Am Heart J; 2004 Mar; 147(3):502-8. PubMed ID: 14999201
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study.
    Assmann G, Schulte H, Cullen P, Seedorf U.
    Eur J Clin Invest; 2007 Dec; 37(12):925-32. PubMed ID: 18036028
    [Abstract] [Full Text] [Related]

  • 6. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
    Benn M, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A.
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):661-70. PubMed ID: 17170368
    [Abstract] [Full Text] [Related]

  • 7. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.
    Ferrario M, Chiodini P, Chambless LE, Cesana G, Vanuzzo D, Panico S, Sega R, Pilotto L, Palmieri L, Giampaoli S, CUORE Project Research Group.
    Int J Epidemiol; 2005 Apr; 34(2):413-21. PubMed ID: 15659467
    [Abstract] [Full Text] [Related]

  • 8. [A 20-year prospective study on risk factors for myocardial infarction of 5,137 men in Capital Steel and Iron Company].
    Yue H, Gu DF, Wu XG, Yu XH, Duan XF, Wang JH, Zheng RP, Zhou J.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Jan; 38(1):43-6. PubMed ID: 14989905
    [Abstract] [Full Text] [Related]

  • 9. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.
    Koenig W, Löwel H, Baumert J, Meisinger C.
    Circulation; 2004 Mar 23; 109(11):1349-53. PubMed ID: 15023871
    [Abstract] [Full Text] [Related]

  • 10. [Cardiac risk in men with angiographically normal coronary arteries or minimal coronary arteriosclerosis].
    Schulz H, Sinn R, Wolf R.
    Z Kardiol; 2003 Mar 23; 92(3):245-53. PubMed ID: 12658472
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS).
    Holme I, Aastveit AH, Jungner I, Walldius G.
    J Intern Med; 2008 Jul 23; 264(1):30-8. PubMed ID: 18298486
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apolipoproteins A-I and B-markers in coronary risk evaluation.
    Agoston-Coldea L, Zdrenghea D, Pop D, Crăciun A, Rusu ML, Mocan T.
    Rom J Intern Med; 2007 Jul 23; 45(3):251-8. PubMed ID: 18333357
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study.
    Assmann G, Schulte H, Seedorf U.
    Int J Obes (Lond); 2008 May 23; 32 Suppl 2():S11-6. PubMed ID: 18469834
    [Abstract] [Full Text] [Related]

  • 16. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
    Kiechl S, Willeit J, Mayr M, Viehweider B, Oberhollenzer M, Kronenberg F, Wiedermann CJ, Oberthaler S, Xu Q, Witztum JL, Tsimikas S.
    Arterioscler Thromb Vasc Biol; 2007 Aug 23; 27(8):1788-95. PubMed ID: 17541022
    [Abstract] [Full Text] [Related]

  • 17. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE, von Eckardstein A, Schulte H, Cullen P, Assmann G.
    Eur J Cardiovasc Prev Rehabil; 2007 Apr 23; 14(2):230-6. PubMed ID: 17446801
    [Abstract] [Full Text] [Related]

  • 18. Impact of follow-up time and re-measurement of the electrocardiogram and conventional cardiovascular risk factors on their predictive value for myocardial infarction.
    Möller CS, Zethelius B, Sundström J, Lind L.
    J Intern Med; 2006 Jul 23; 260(1):22-30. PubMed ID: 16789975
    [Abstract] [Full Text] [Related]

  • 19. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study.
    Assmann G, Cullen P, Heinrich J, Schulte H.
    Isr J Med Sci; 1996 Jun 23; 32(6):364-70. PubMed ID: 8682642
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.